Literature DB >> 11198885

Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.

D L Morton1, D W Ollila, E C Hsueh, R Essner, R K Gupta.   

Abstract

Although patients with metastatic disease are usually not offered surgery as part of their comprehensive treatment plan, the authors suggest that surgical reduction of the tumor burden may enhance the host immune response and create a favorable setting for the use of active specific immunotherapy.

Entities:  

Mesh：

Year:  1999        PMID： 11198885     DOI： 10.3322/canjclin.49.2.101

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  17 in total

1.  Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).

Authors:  J Harrison Howard; John F Thompson; Nicola Mozzillo; Omgo E Nieweg; Harald J Hoekstra; Daniel F Roses; Vernon K Sondak; Douglas S Reintgen; Mohammed Kashani-Sabet; Constantine P Karakousis; Brendon J Coventry; William G Kraybill; B Mark Smithers; Robert Elashoff; Stacey L Stern; Alistair J Cochran; Mark B Faries; Donald L Morton
Journal:  Ann Surg Oncol       Date:  2012-05-31       Impact factor: 5.344

Review 2.  Surgery and sentinel lymph node biopsy.

Authors:  Mark B Faries; Donald L Morton
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

Review 3.  [Influence of anesthesia procedure on malignant tumor outcome].

Authors:  K Fukui; C Werner; G Pestel
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 4.  Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines.

Authors:  Marijo Bilusic; James L Gulley
Journal:  Cancer Immunol Immunother       Date:  2011-11-26       Impact factor: 6.968

5.  Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.

Authors:  E A Mittendorf; G T Clifton; J P Holmes; E Schneble; D van Echo; S Ponniah; G E Peoples
Journal:  Ann Oncol       Date:  2014-06-06       Impact factor: 32.976

Review 6.  Surgery for distant melanoma metastasis.

Authors:  Anna M Leung; Danielle M Hari; Donald L Morton
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

Review 7.  The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy.

Authors:  Siavash Raigani; Sonia Cohen; Genevieve M Boland
Journal:  Curr Oncol Rep       Date:  2017-03       Impact factor: 5.075

8.  Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.

Authors:  Nabil Wasif; Sanjay P Bagaria; Partha Ray; Donald L Morton
Journal:  J Surg Oncol       Date:  2011-03-04       Impact factor: 3.454

9.  Improved survival for stage IV melanoma from an unknown primary site.

Authors:  Chris C Lee; Mark B Faries; Leslie A Wanek; Donald L Morton
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

10.  Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.

Authors:  Donald L Morton; Eddy C Hsueh; Richard Essner; Leland J Foshag; Steven J O'Day; Anton Bilchik; Rishab K Gupta; Dave S B Hoon; Mepur Ravindranath; J Anne Nizze; Guy Gammon; Leslie A Wanek; He-Jing Wang; Robert M Elashoff
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.